← Back to Search

Unknown

PDI-320 for Rosacea

Phase 2
Waitlist Available
Research Sponsored by PreCision Dermatology, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 4 and week 8
Awards & highlights

Study Summary

This 4-arm Phase 2 vehicle-controlled study is designed to assess the safety and efficacy of PDI-320, and the individual components, in adult subjects with rosacea.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 4 and week 8
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 4 and week 8 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Inflammation
Treatment "Success Rate" based on change in Investigator's Global Assessment (IGA)
Secondary outcome measures
Absolute change in inflammatory lesion count (interim time points)
Change in erythema severity
Change in telangiectasia severity
+1 more

Trial Design

4Treatment groups
Experimental Treatment
Placebo Group
Group I: PDI-320 Monad #2Experimental Treatment1 Intervention
Foam, twice daily for up to 12 weeks
Group II: PDI-320 Monad #1Experimental Treatment1 Intervention
Foam, twice daily for up to 12 weeks
Group III: PDI-320Experimental Treatment1 Intervention
Foam, twice daily for up to 12 weeks
Group IV: VehiclePlacebo Group1 Intervention
Foam, twice daily for up to 12 weeks

Find a Location

Who is running the clinical trial?

PreCision Dermatology, Inc.Lead Sponsor
1 Previous Clinical Trials
151 Total Patients Enrolled
Syd Dromgoole, PhDStudy DirectorTherapeutics, Inc.
4 Previous Clinical Trials
292 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
An Evaluation of PDI-320 in Comparison to Its Monads in Adults With Rosacea
2013. "An Evaluation of PDI-320 in Comparison to Its Monads in Adults With Rosacea". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01828177.
All > Osa > Rosacea
~17 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top